Shanghai Yuli Biotechnology Co., Ltd. is a trusted Contract Development and Manufacturing Organization (CDMO) in the field of global peptide drug development. Located in the Shanghai Jindi Vx Life Science Industrial Park, our company operates a 5,000-square-meter modern production facility that currently complies with GMP-like quality management systems. We are scheduled to fully upgrade to cGMP standards aligned with China, the U.S., and the European Union by the third quarter of 2026. Continuously committed to meeting the requirements for relevant Green/Priority Review pathways, we ensure globally consistent, top-tier quality assurance for all our clients.